LABD vs SDS
Direxion Daily S&P Biotech Bear 3X ETF against ProShares UltraShort S&P500: cost, size, returns, what they hold and how much of it is the same.
Fee gap
16 bp
SDS is cheaper
1-year return gap
53.0 pts
SDS is ahead
Larger fund
SDS
$405M
Side by side
| LABD | SDS | |
|---|---|---|
| Fund | Direxion Daily S&P Biotech Bear 3X ETF | ProShares UltraShort S&P500 |
| Issuer | Direxion | ProShares |
| Category | Inverse Equity | Inverse Equity |
| Expense ratio | 1.07% | 0.91% |
| Assets | $79M | $405M |
| Average daily dollar volume | $191M | $259M |
| Listed | May 28, 2015 | Jul 11, 2006 |
| FrenzyCap score | 54 | 77 |
| 1-month return | −7.8% | +4.5% |
| 3-month return | +1.9% | +4.3% |
| Year to date | −64.8% | −18.5% |
| 1-year return | −72.3% | −19.3% |
| 30-day volatility | 117.9% | 37.5% |
| Worst drawdown, 1 year | −79.1% | −34.5% |
| Trailing 12-month yield | 6.20% | 5.07% |
| Holdings | 10 | 26 |
| Top 10 weight | 0.0% | 37.5% |
| Look-through P/E | — | — |
| Holdings vs fair value | — | — |
| Holdings above 200-day average | — | — |
| Net flow, latest 3 reported months | +$16M thru Jul 2026 | −$48M thru Aug 2026 |
| 30-day implied volatility | 98.7% | 31.0% |
| Holdings as of | as of Nov 13, 2026issuer data | as of Nov 13, 2026issuer data |
Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.
More: full overlap table · LABD holdings · SDS holdings
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.